Translation of Human-Induced Pluripotent Stem Cells from Clinical Trial in a Dish to Precision Medicine

Journal of the American College of Cardiology

Volumn 67, Issue 18, 2016, Pages 2161-2176

  Sayed, Nazish ^a   Liu, Chun ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug discovery; human induced pluripotent stem cells; macromedicine; micromedicine; personalized medicine

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; BONE MARROW CELL; CARDIAC MUSCLE CELL; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL SELF-RENEWAL; CYTOSKELETON; DISEASE COURSE; EMBRYONIC STEM CELL; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN GENOME; INDUCED PLURIPOTENT STEM CELL; MEDICAL RESEARCH; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REPRODUCIBILITY; REVIEW; TISSUE ENGINEERING; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASES; CELL TRANSDIFFERENTIATION; DRUG DEVELOPMENT; PERSONALIZED MEDICINE; PHARMACOGENETICS; TRANSLATIONAL RESEARCH;

CARDIOVASCULAR DISEASES; CELL TRANSDIFFERENTIATION; DRUG DISCOVERY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; PHARMACOGENETICS; PRECISION MEDICINE; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84966638796     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.01.083     Document Type: Review

References (174)

1. J.E. Till, and E.A. McCulloch A direct measurement of the radiation sensitivity of normal mouse bone marrow cells Radiat Res 14 1961 213 222
2. J.B. Gurdon The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles J Embryol Exp Morphol 10 1962 622 640
3. I. Wilmut, A.E. Schnieke, J. McWhir, A.J. Kind, and K.H. Campbell Viable offspring derived from fetal and adult mammalian cells [published correction appears in Nature 1997;386:200] Nature 385 1997 810 813
4. M.J. Evans, and M.H. Kaufman Establishment in culture of pluripotential cells from mouse embryos Nature 292 1981 154 156
5. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, and et al. Embryonic stem cell lines derived from human blastocysts [published correction appears in Science 1998;282:1827] Science 282 1998 1145 1147
6. M. Tada, Y. Takahama, K. Abe, N. Nakatsuji, and T. Tada Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells Curr Biol 11 2001 1553 1558
7. R.L. Davis, H. Weintraub, and A.B. Lassar Expression of a single transfected cDNA converts fibroblasts to myoblasts Cell 51 1987 987 1000
8. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
9. K. Takahashi, K. Tanabe, M. Ohnuki, and et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
10. A. Marson, R. Foreman, B. Chevalier, and et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency Cell Stem Cell 3 2008 132 135
11. D. Huangfu, R. Maehr, W. Guo, and et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds Nat Biotech 26 2008 795 797
12. J.T. Dimos, K.T. Rodolfa, K.K. Niakan, and et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons Science 321 2008 1218 1221
13. J. Hanna, S. Markoulaki, P. Schorderet, and et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency [published correction appears in Cell 2008;134:365] Cell 133 2008 250 264
14. N. Sun, N.J. Panetta, D.M. Gupta, and et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells Proc Natl Acad Sci U S A 106 2009 15720 15725
15. J. Yu, M.A. Vodyanik, K. Smuga-Otto, and et al. Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
16. Y. Zhao, X. Yin, H. Qin, and et al. Two supporting factors greatly improve the efficiency of human iPSC generation Cell Stem Cell 3 2008 475 479
17. K. Woltjen, I.P. Michael, P. Mohseni, and et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells Nature 458 2009 766 770
18. B.W. Carey, S. Markoulaki, J. Hanna, and et al. Reprogramming of murine and human somatic cells using a single polycistronic vector [published corrections appear in Proc Natl Acad Sci U S A 2009;106:5449 and Proc Natl Acad Sci U S A 2009;106:11818] Proc Natl Acad Sci U S A 106 2009 157 162
19. F. Jia, K.D. Wilson, N. Sun, and et al. A nonviral minicircle vector for deriving human iPS cells Nat Methods 7 2010 197 199
20. M. Wernig, C.J. Lengner, J. Hanna, and et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types Nat Biotechnol 26 2008 916 924
21. L. Warren, P.D. Manos, T. Ahfeldt, and et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
22. H. Zhou, S. Wu, J.Y. Joo, and et al. Generation of induced pluripotent stem cells using recombinant proteins [published correction appears in Cell Stem Cell 2009;4:581] Cell Stem Cell 4 2009 381 384
23. J. Lee, N. Sayed, A. Hunter, and et al. Activation of innate immunity is required for efficient nuclear reprogramming Cell 151 2012 547 558
24. P. Hou, Y. Li, X. Zhang, and et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds Science 341 2013 651 654
25. E. Neofytou, C.G. O'Brien, L.A. Couture, and J.C. Wu Hurdles to clinical translation of human induced pluripotent stem cells J Clin Invest 125 2015 2551 2557
26. E.A. Kimbrel, and R. Lanza Current status of pluripotent stem cells: moving the first therapies to the clinic Nat Rev Drug Discov 14 2015 681 692
27. P.W. Burridge, G. Keller, J.D. Gold, and J.C. Wu Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming Cell Stem Cell 10 2012 16 28
28. E. Matsa, P.W. Burridge, and J.C. Wu Human stem cells for modeling heart disease and for drug discovery Sci Transl Med 6 2014 239ps6
29. P.W. Burridge, E. Matsa, P. Shukla, and et al. Chemically defined generation of human cardiomyocytes Nat Methods 11 2014 855 860
30. F.S. Collins, and H. Varmus A new initiative on precision medicine N Engl J Med 372 2015 793 795
31. J.M. Polo, E. Anderssen, R.M. Walsh, and et al. A molecular roadmap of reprogramming somatic cells into iPS cells Cell 151 2012 1617 1632
32. Y. Buganim, D.A. Faddah, A.W. Cheng, and et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase Cell 150 2012 1209 1222
33. Y. Rais, A. Zviran, S. Geula, and et al. Deterministic direct reprogramming of somatic cells to pluripotency [published correction appears in Nature 2015;520:710] Nature 502 2013 65 70
34. M.H. Chin, M.J. Mason, W. Xie, and et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures Cell Stem Cell 5 2009 111 123
35. Z. Ghosh, K.D. Wilson, Y. Wu, S. Hu, T. Quertermous, and J.C. Wu Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells PLoS One 5 2010 e8975
36. J. Deng, R. Shoemaker, B. Xie, and et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming Nat Biotechnol 27 2009 353 360
37. C. Bock, E. Kiskinis, G. Verstappen, and et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines Cell 144 2011 439 452
38. M.G. Guenther, G.M. Frampton, F. Soldner, and et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells Cell Stem Cell 7 2010 249 257
39. A.M. Newman, and J.B. Cooper Lab-specific gene expression signatures in pluripotent stem cells Cell Stem Cell 7 2010 258 262
40. J. Choi, S. Lee, W. Mallard, and et al. A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs Nat Biotech 33 2015 1173 1181
41. N. Sayed, W.T. Wong, and J.P. Cooke Therapeutic transdifferentiation: can we generate cardiac tissue rather than scar after myocardial injury? Methodist Debakey Cardiovasc J 9 2013 210 212
42. T. Vierbuchen, A. Ostermeier, Z.P. Pang, Y. Kokubu, T.C. Südhof, and M. Wernig Direct conversion of fibroblasts to functional neurons by defined factors Nature 463 2010 1035 1041
43. P. Huang, Z. He, S. Ji, and et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors Nature 475 2011 386 389
44. M. Ieda, J.D. Fu, P. Delgado-Olguin, and et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors Cell 142 2010 375 386
45. A. Margariti, B. Winkler, E. Karamariti, and et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels Proc Natl Acad Sci U S A 109 2012 13793 13798
46. N. Sayed, W.T. Wong, F. Ospino, and et al. Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity Circulation 131 2015 300 309
47. J.X. Chen, M. Krane, M.A. Deutsch, and et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5 Circ Res 111 2012 50 55
48. A.D. Ebert, S. Diecke, I.Y. Chen, and J.C. Wu Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? EMBO Mol Med 7 2015 1090 1103
49. F.T. Merkle, and K. Eggan Modeling human disease with pluripotent stem cells: from genome association to function Cell Stem Cell 12 2013 656 668
50. I.H. Park, N. Arora, H. Huo, and et al. Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
51. X. Carvajal-Vergara, A. Sevilla, S.L. D'Souza, and et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 2010 808 812
52. M.C.N. Marchetto, B. Winner, and F.H. Gage Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases Hum Mol Genet 19 2010 R71 R76
53. A. Moretti, M. Bellin, A. Welling, and et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome N Engl J Med 363 2010 1397 1409
54. I. Itzhaki, L. Maizels, I. Huber, and et al. Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 2011 225 229
55. E. Matsa, D. Rajamohan, E. Dick, and et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation Eur Heart J 32 2011 952 962
56. K. Narsinh, K.H. Narsinh, and J.C. Wu Derivation of human induced pluripotent stem cells for cardiovascular disease modeling Circ Res 108 2011 1146 1156
57. A. Filareto, S. Parker, R. Darabi, and et al. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells Nat Commun 4 2013 1549
58. B. Lin, Y. Li, L. Han, and et al. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy Dis Model Mech 8 2015 457 466
59. Á. Raya, I. Rodríguez-Pizà, G. Guenechea, and et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells Nature 460 2009 53 59
60. A. Urbach, O. Bar-Nur, G.Q. Daley, and N. Benvenisty Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells Cell Stem Cell 6 2010 407 411
61. A. Novak, L. Barad, A. Lorber, and et al. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations J Cell Mol Med 19 2015 2006 2018
62. F. Lan, A.S. Lee, P. Liang, and et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells Cell Stem Cell 12 2013 101 113
63. C.W. Siu, Y.K. Lee, J.C. Ho, and et al. Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells Aging (Albany NY) 4 2012 803 822
64. N. Sun, M. Yazawa, J. Liu, and et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy Sci Transl Med 4 2012 130ra47
65. H. Wu, J. Lee, L.G. Vincent, and et al. Epigenetic regulation of phosphodiesterases 2A and 3A underlies compromised β-adrenergic signaling in an iPSC model of dilated cardiomyopathy Cell Stem Cell 17 2015 89 100
66. J.T. Hinson, A. Chopra, N. Nafissi, and et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy Science 349 2015 982 986
67. H.F. Tse, J.C. Ho, S.W. Choi, and et al. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing [published correction appears in Hum Mol Genet 2014;23:2332-3] Hum Mol Genet 22 2013 1395 1403
68. I. Karakikes, F. Stillitano, M. Nonnenmacher, and et al. Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy Nat Commun 6 2015 6955
69. M.J. Birket, M.C. Ribeiro, G. Kosmidis, and et al. Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function Cell Rep 13 2015 733 745
70. G. Wang, M.L. McCain, L. Yang, and et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies Nat Med 20 2014 616 623
71. Y. Wang, P. Liang, F. Lan, and et al. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing J Am Coll Cardiol 64 2014 451 459
72. D. Ma, H. Wei, Y. Zhao, and et al. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells Int J Cardiol 168 2013 5277 5286
73. M. Yazawa, B. Hsueh, X. Jia, and et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome Nature 471 2011 230 234
74. C. Kim, J. Wong, J. Wen, and et al. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs Nature 494 2013 105 110
75. Y. Sato, H. Kobayashi, T. Higuchi, and et al. Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient Mol Ther Methods Clin Dev 2 2015 15023
76. Y.K. Lee, P.W. Ho, R. Schick, and et al. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells Pflugers Arch 466 2014 1831 1844
77. P.W. Burridge, A. Holmström, and J.C. Wu Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells Curr Protoc Hum Genet 87 2015 21.3.1 21.3.15
78. N.M. Mordwinkin, A.S. Lee, and J.C. Wu Patient-specific stem cells and cardiovascular drug discovery JAMA 310 2013 2039 2040
79. T. Egashira, S. Yuasa, T. Suzuki, and et al. Disease characterization using LQTS-specific induced pluripotent stem cells Cardiovasc Res 95 2012 419 429
80. A.L. Lahti, V.J. Kujala, H. Chapman, and et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture Dis Model Mech 5 2012 220 230
81. C.B. Jung, A. Moretti, M. Mederos y Schnitzler, and et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia EMBO Mol Med 4 2012 180 191
82. A. Novak, L. Barad, N. Zeevi-Levin, and et al. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation J Cell Mol Med 16 2012 468 482
83. A. Asimaki, S. Kapoor, E. Plovie, and et al. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy [published correction appears in Sci Transl Med 2014;6:261er6] Sci Transl Med 6 2014 240ra74
84. E.G. Navarrete, P. Liang, F. Lan, and et al. Screening drug-induced arrhythmia using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays [published correction appears in Circulation 2014;129:e452] Circulation 128 2013 S3 S13
85. P. Liang, F. Lan, A.S. Lee, and et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity Circulation 127 2013 1677 1691
86. F.M. Drawnel, S. Boccardo, M. Prummer, and et al. Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells Cell Rep 9 2014 810 821
87. A. Sharma, C. Marceau, R. Hamaguchi, and et al. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform Circ Res 115 2014 556 566
88. P. Aggarwal, A. Turner, A. Matter, and et al. RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model PLoS One 9 2014 e108051
89. A.D. Ebert, K. Kodo, P. Liang, and et al. Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system Sci Transl Med 6 2014 255ra130
90. X. Lian, J. Zhang, S.M. Azarin, and et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions Nat Protoc 8 2013 162 175
91. J. Zhang, G.F. Wilson, A.G. Soerens, and et al. Functional cardiomyocytes derived from human induced pluripotent stem cells Circ Res 104 2009 e30 e41
92. X. Yang, L. Pabon, and C.E. Murry Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes Circ Res 114 2014 511 523
93. I. Karakikes, M. Ameen, V. Termglinchan, and J.C. Wu Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes Circ Res 117 2015 80 88
94. M. Snir, I. Kehat, A. Gepstein, and et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes Am J Physiol Heart Circ Physiol 285 2003 H2355 H2363
95. C.C. Veerman, G. Kosmidis, C.L. Mummery, S. Casini, A.O. Verkerk, and M. Bellin Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem? Stem Cells Dev 24 2015 1035 1052
96. M. Mollova, K. Bersell, S. Walsh, and et al. Cardiomyocyte proliferation contributes to heart growth in young humans Proc Natl Acad Sci U S A 110 2013 1446 1451
97. S.D. Lundy, W.Z. Zhu, M. Regnier, and M.A. Laflamme Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells Stem Cells Dev 22 2013 1991 2002
98. C.Y. Ivashchenko, G.C. Pipes, I.M. Lozinskaya, and et al. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype Am J Physiol Heart Circ Physiol 305 2013 H913 H922
99. M.M. LeWinter, and H.L. Granzier Cardiac titin and heart disease J Cardiovasc Pharmacol 63 2014 207 212
100. F.B. Bedada, S.S.K. Chan, S.K. Metzger, and et al. Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes Stem Cell Reports 3 2014 594 605
101. J. Ma, L. Guo, S.J. Fiene, and et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents Am J Physiol Heart Circ Physiol 301 2011 H2006 H2017
102. R.P. Davis, S. Casini, C.W. van den Berg, and et al. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease Circulation 125 2012 3079 3091
103. + current in human induced pluripotent stem cell-derived cardiomyocytes J Mol Cell Cardiol 60 2013 36 46
104. H.D. Devalla, V. Schwach, J.W. Ford, and et al. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology EMBO Mol Med 7 2015 394 410
105. P. Lee, M. Klos, C. Bollensdorff, and et al. Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers Circ Res 110 2012 1556 1563
106. A. Vreeker, L. van Stuijvenberg, T.J. Hund, P.J. Mohler, P.G. Nikkels, and T.A. van Veen Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart PLoS One 9 2014 e94722
107. I. Itzhaki, S. Rapoport, I. Huber, and et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes PLoS One 6 2011 e18037
108. O. Binah, K. Dolnikov, O. Sadan, and et al. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes J Electrocardiol 40 Suppl 2007 S192 S196
109. J. Liu, J.D. Fu, C.W. Siu, and R.A. Li Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation Stem Cells 25 2007 3038 3044
110. N.L. Tulloch, V. Muskheli, M.V. Razumova, and et al. Growth of engineered human myocardium with mechanical loading and vascular coculture Circ Res 109 2011 47 59
111. J. Synnergren, C. Améen, A. Jansson, and P. Sartipy Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue Physiol Genomics 44 2012 245 258
112. R.F. Wiegerinck, A. Cojoc, C.M. Zeidenweber, and et al. Force frequency relationship of the human ventricle increases during early postnatal development Pediatr Res 65 2009 414 419
113. W. Keung, K.R. Boheler, and R.A. Li Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes Stem Cell Res Ther 5 2014 17
114. J.C. St John, J. Ramalho-Santos, H.L. Gray, and et al. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells Cloning Stem Cells 7 2005 141 153
115. S. Chung, P.P. Dzeja, R.S. Faustino, C. Perez-Terzic, A. Behfar, and A. Terzic Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells Nat Clin Pract Cardiovasc Med 4 Suppl 1 2007 S60 S67
116. G.D. Lopaschuk, R.L. Collins-Nakai, and T. Itoi Developmental changes in energy substrate use by the heart Cardiovasc Res 26 1992 1172 1180
117. F. Pillekamp, M. Haustein, M. Khalil, and et al. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy Stem Cells Dev 21 2012 2111 2121
118. G. Földes, E. Matsa, J. Kriston-Vizi, and et al. Aberrant α-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells Stem Cell Reports 3 2014 905 914
119. J.G. Jacot, A.D. McCulloch, and J.H. Omens Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes Biophys J 95 2008 3479 3487
120. E. Tzatzalos, O.J. Abilez, P. Shukla, and J.C. Wu Engineered heart tissues and induced pluripotent stem cells: macro- and microstructures for disease modeling, drug screening, and translational studies Adv Drug Deliv Rev 96 2016 234 244
121. J.D. Fu, S.N. Rushing, D.K. Lieu, and et al. Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes PLoS One 6 2011 e27417
122. K.D. Wilson, S. Hu, S. Venkatasubrahmanyam, and et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499 Circ Cardiovasc Genet 3 2010 426 435
123. C.L. Zhang, T.A. McKinsey, S. Chang, C.L. Antos, J.A. Hill, and E.N. Olson Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy Cell 110 2002 479 488
124. R. Gilsbach, S. Preissl, B.A. Grüning, and et al. Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease Nat Commun 5 2014 5288
125. K.T. Kuppusamy, D.C. Jones, H. Sperber, and et al. Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes Proc Natl Acad Sci U S A 112 2015 E2785 E2794
126. G. Földes, M. Mioulane, J.S. Wright, and et al. Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J Mol Cell Cardiol 50 2011 367 376
127. N.N. Chattergoon, G.D. Giraud, S. Louey, P. Stork, A.L. Fowden, and K.L. Thornburg Thyroid hormone drives fetal cardiomyocyte maturation FASEB J 26 2012 397 408
128. H. Kim, and J.S. Kim A guide to genome engineering with programmable nucleases Nat Rev Genet 15 2014 321 334
129. K.M. Esvelt, and H.H. Wang Genome-scale engineering for systems and synthetic biology Mol Syst Biol 9 2013 641
130. M. Bellin, S. Casini, R.P. Davis, and et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome EMBO J 32 2013 3161 3175
131. C. Long, J.R. McAnally, J.M. Shelton, A.A. Mireault, R. Bassel-Duby, and E.N. Olson Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA Science 345 2014 1184 1188
132. D.B.T. Cox, R.J. Platt, and F. Zhang Therapeutic genome editing: prospects and challenges Nat Med 21 2015 121 131
133. ClinicalTrials.gov. NCT01344993. NCT01345006. NCT01469832. NCT01625559. NCT01674829. NCT01691261. NCT02122159. NCT02286089. NCT02464956. Available at: https://clinicaltrials.gov. Accessed February 27, 2016.
134. B. Lu, C. Malcuit, S. Wang, and et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration Stem Cells 27 2009 2126 2135
135. H. Kamao, M. Mandai, S. Okamoto, and et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application Stem Cell Reports 2 2014 205 218
136. T. Yoshida, Y. Ozawa, K. Suzuki, and et al. The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa Mol Brain 7 2014 45
137. Y. Li, Y.T. Tsai, C.W. Hsu, and et al. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa Mol Med 18 2012 1312 1319
138. H. Liu, Y. Kim, S. Sharkis, L. Marchionni, and Y.Y. Jang In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins Sci Transl Med 3 2011 82ra39
139. S. Nori, Y. Okada, A. Yasuda, and et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice Proc Natl Acad Sci U S A 108 2011 16825 16830
140. Q. Tan, P.P.Y. Lui, Y.F. Rui, and Y.M. Wong Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering Tissue Eng Part A 18 2011 840 851
141. N. Suzuki, S. Yamazaki, T. Yamaguchi, and et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation Mol Ther 21 2013 1424 1431
142. M.A. Laflamme, K.Y. Chen, A.V. Naumova, and et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat Biotechnol 25 2007 1015 1024
143. O. Caspi, I. Huber, I. Kehat, and et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts J Am Coll Cardiol 50 2007 1884 1893
144. F. Cao, R.A. Wagner, K.D. Wilson, and et al. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes PLoS One 3 2008 e3474
145. Y. Shiba, S. Fernandes, W.Z. Zhu, and et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts Nature 489 2012 322 325
146. L. Ye, Y.H. Chang, Q. Xiong, and et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells [published correction appears in Cell Stem Cell 2015;16:102] Cell Stem Cell 15 2014 750 761
147. J.J.H. Chong, X. Yang, C.W. Don, and et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts Nature 510 2014 273 277
148. M.E. Anderson, J. Goldhaber, S.R. Houser, M. Puceat, and M.A. Sussman Embryonic stem cell-derived cardiac myocytes are not ready for human trials Circ Res 115 2014 335 338
149. C.E. Murry, J.J.H. Chong, and M.A. Laflamme Letter by Murry et al regarding article, "Embryonic stem cell-derived cardiac myocytes are not ready for human trials." Circ Res 115 2014 e28 e29
150. Assistance Publique-Hôpitaux de Paris. Transplantation of human embryonic stem cell-derived progenitors in severe heart failure (ESCORT). ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT02057900. Accessed February 27, 2016.
151. V. Bellamy, V. Vanneaux, A. Bel, and et al. Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold J Heart Lung Transplant 34 2015 1198 1207
152. P. Menasché, V. Vanneaux, A. Hagège, and et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report Eur Heart J 36 2015 2011 2017
153. J. Riegler, A. Gillich, Q. Shen, J.D. Gold, and J.C. Wu Cardiac tissue slice transplantation as a model to assess tissue-engineered graft thickness, survival, and function Circulation 130 11 Suppl 1 2014 S77 S86
154. D.A. Pijnappels, M.J. Schalij, D.E. Atsma, and A.A. de Vries Cardiac anisotropy, regeneration, and rhythm Circ Res 115 2014 e6 e7
155. L. Ye, W.H. Zimmermann, D.J. Garry, and J. Zhang Patching the heart: cardiac repair from within and outside Circ Res 113 2013 922 932
156. Q. Xiong, L. Ye, P. Zhang, and et al. Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells Circ Res 111 2012 455 468
157. Q. Xiong, L. Ye, P. Zhang, and et al. Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling Circulation 127 2013 997 1008
158. J. Riegler, M. Tiburcy, A. Ebert, and et al. Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model Circ Res 117 2015 720 730
159. Q. Xiong, K.L. Hill, Q. Li, and et al. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling Stem Cells 29 2011 367 375
160. D. Rajamohan, E. Matsa, S. Kalra, and et al. Current status of drug screening and disease modelling in human pluripotent stem cells Bioessays 35 2013 281 298
161. K. Sallam, Y. Li, P.T. Sager, S.R. Houser, and J.C. Wu Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes Circ Res 116 2015 1989 2004
162. C.P. Adams, and V.V. Brantner Spending on new drug development Health Econ 19 2010 130 141
163. B.T. Priest, I.M. Bell, and M.L. Garcia Role of hERG potassium channel assays in drug development Channels (Austin) 2 2008 87 93
164. D. Thomas, C.A. Karle, and J. Kiehn The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications Curr Pharm Des 12 2006 2271 2283
165. S.R. Braam, L. Tertoolen, A. van de Stolpe, T. Meyer, R. Passier, and C.L. Mummery Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes Stem Cell Res 4 2010 107 116
166. M.K. Jonsson, G. Duker, C. Tropp, and et al. Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes Stem Cell Res 4 2010 189 200
167. J.Q. He, Y. Ma, Y. Lee, J.A. Thomson, and T.J. Kamp Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization Circ Res 93 2003 32 39
168. D. Zhang, I.Y. Shadrin, J. Lam, H.Q. Xian, H.R. Snodgrass, and N. Bursac Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes Biomaterials 34 2013 5813 5820
169. P.W. Burridge, A. Sharma, and J.C. Wu Genetic and epigenetic regulation of human cardiac reprogramming and differentiation in regenerative medicine Annu Rev Genet 49 2015 461 484
170. A. Mathur, P. Loskill, K. Shao, and et al. Human iPSC-based cardiac microphysiological system for drug screening applications Sci Rep 5 2015 8883
171. L. Guo, R.M.C. Abrams, J.E. Babiarz, and et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes Toxicol Sci 123 2011 281 289
172. H. Inoue, N. Nagata, H. Kurokawa, and S. Yamanaka iPS cells: a game changer for future medicine EMBO J 33 2014 409 417
173. K.D. Wilson, and J.C. Wu Induced pluripotent stem cells JAMA 313 2015 1613 1614
174. E. Matsa, K. Sallam, and J.C. Wu Cardiac stem cell biology: glimpse of the past, present, and future Circ Res 114 2014 21 27